Treatment of early uterine sarcomas: disentangling adjuvant modalities

Zagouri, F; Dimopoulos, A; Fotiou, S; Kouloulias, V; Papadimitriou, C

dc.contributor.author	Zagouri, F	en
dc.contributor.author	Dimopoulos, A	en
dc.contributor.author	Fotiou, S	en
dc.contributor.author	Kouloulias, V	en
dc.contributor.author	Papadimitriou, C	en
dc.date.accessioned	2014-03-01T01:58:22Z
dc.date.available	2014-03-01T01:58:22Z
dc.date.issued	2009	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/28671
dc.subject	Adjuvant Chemotherapy	en
dc.subject	Clinical Trial	en
dc.subject	Lymph Node Dissection	en
dc.subject	Lymph Node Metastases	en
dc.subject	Radiation Therapy	en
dc.title	Treatment of early uterine sarcomas: disentangling adjuvant modalities	en
heal.type	journalArticle	en
heal.identifier.primary	10.1186/1477-7819-7-38	en
heal.identifier.secondary	http://dx.doi.org/10.1186/1477-7819-7-38	en
heal.publicationDate	2009	en
heal.abstract	Uterine sarcomas are a rare group of neoplasms with aggressive clinical course and poor prognosis. They are classified into four main histological subtypes in order of decreasing incidence: carcinosarcomas, leiomyosarcomas, endometrial stromal sarcomas and "other" sarcomas. The pathological subtype demands a tailored approach. Surgical resection is regarded as the mainstay of treatment. Total abdominal hysterectomy and bilateral salpingo-oophorectomy represents the	en
heal.journalName	World Journal of Surgical Oncology	en
dc.identifier.doi	10.1186/1477-7819-7-38	en